StockNews.com assumed coverage on shares of Edap Tms (NASDAQ:EDAP - Free Report) in a research note issued to investors on Friday morning. The brokerage issued a hold rating on the medical equipment provider's stock.
Edap Tms Price Performance
Shares of EDAP traded up $0.14 during mid-day trading on Friday, reaching $2.44. The company had a trading volume of 29,914 shares, compared to its average volume of 40,516. The company's 50 day simple moving average is $2.27 and its 200 day simple moving average is $3.00. The company has a market capitalization of $90.52 million, a price-to-earnings ratio of -3.75 and a beta of 0.36. Edap Tms has a 1-year low of $2.00 and a 1-year high of $8.50. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.46 and a current ratio of 2.18.
Edap Tms (NASDAQ:EDAP - Get Free Report) last issued its earnings results on Thursday, November 7th. The medical equipment provider reported ($0.19) earnings per share for the quarter, missing analysts' consensus estimates of ($0.16) by ($0.03). Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. The company had revenue of $14.42 million during the quarter, compared to analyst estimates of $17.00 million. During the same quarter in the prior year, the business earned ($0.12) EPS. Analysts expect that Edap Tms will post -0.6 EPS for the current year.
Institutional Investors Weigh In On Edap Tms
Large investors have recently added to or reduced their stakes in the business. Redhawk Wealth Advisors Inc. acquired a new position in Edap Tms in the third quarter valued at approximately $36,000. BNP Paribas Financial Markets lifted its position in shares of Edap Tms by 23.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider's stock valued at $59,000 after acquiring an additional 4,400 shares during the period. Orion Capital Management LLC lifted its position in shares of Edap Tms by 10.4% during the 3rd quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider's stock valued at $178,000 after acquiring an additional 6,600 shares during the period. Finally, Parkman Healthcare Partners LLC bought a new position in Edap Tms during the third quarter worth $395,000. Institutional investors and hedge funds own 62.74% of the company's stock.
About Edap Tms
(
Get Free Report)
EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.
Featured Stories
Before you consider Edap Tms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Edap Tms wasn't on the list.
While Edap Tms currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
